missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Laquinimod, MedChemExpress
Description
Laquinimod reduces astrocytic NF-κB activation to protect from Cuprizone-induced demyelination. Laquinimod has the potential for relapsing remitting (RR) and chronic progressive (CP) forms of multiple sclerosis (MS; RRMS or CPMS) as well as neurodegenerative diseases research.
Specifications
Specifications
| Chemical Name or Material | Laquinimod |
| Physical Form | Solid |
| CAS | 248281-84-7 |
| Color | White |
| Quantity | 10 mg |
| Purity Grade Notes | Research |
| Molecular Formula | C19H17ClN2O3 |
| For Use With (Application) | COVID-19-immunoregulation |
| Synonym | ABR-215062 |
| Solubility Information | DMSO : 100 mg/mL (280.27 mM; Need ultrasonic) |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?